Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FGF10/FGF17 as prognostic and drug response markers in acute myeloid leukemia.

Current research in translational medicine - 1 Jan 2022

Ling Yanying, Du Qinghua

Abstract excerpt

BACKGROUND: Fibroblast growth factors (FGFs) play important roles in solid tumor progression. Little is known about the function and the prognostic value of distinct FGFs in acute myeloid leukemia (AML). METHODS: We used dataset from Beat AML to screen the FGFs family in AML by log-rank test. Subsequently, we identified the biological functions and the crucial signaling pathways associated with these screened...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fibroblast Growth Factor 10
Share to Fibroblast Growth Factors
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Pharmaceutical Preparations

Share to Phosphatidylinositol 3-Kinases

Share to Prognosis

Source

Identifiers

PMID: 34731724
DOI: 10.1016/j.retram.2021.103316

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FGF10/FGF17 as prognostic and drug response markers in acute myeloid leukemia.PMID 34731724Read ↗

Identification and validation of lymphangiogenesis-related genes for predicting acute myeloid leukemia prognosis: insights from bulk RNA sequencing and single-cell RNA sequencing analyses.Semantic proximity Read ↗

Dysregulated MAPK signaling pathway in acute myeloid leukemia with RUNX1 mutations.Semantic proximity Read ↗

Prognostic role of chemokine-related genes in acute myeloid leukemiaSemantic proximity Read ↗

FHL1 as a prognostic biomarker and therapeutic target in acute myeloid leukemiaSemantic proximity Read ↗

CXCR4 as a therapeutic target in acute myeloid leukemia.Semantic proximity Read ↗

Genomic Discovery of EF-24 Targets Unveils Antitumorigenic Mechanisms in Leukemia CellsSemantic proximity Read ↗

IGF2BP2 Overexpression Indicates Poor Survival in Patients with Acute Myelocytic LeukemiaSemantic proximity Read ↗

Landscape of FGF/FGFR Alterations in 12,372 Chinese Cancer PatientsSemantic proximity Read ↗

Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemiaSemantic proximity Read ↗

High Expression of PXN Predicts a Poor Prognosis in Acute myeloid leukemiaSemantic proximity Read ↗

High-throughput analysis of genome-wide receptor tyrosine kinase expression in human cancers identifies potential novel drug targets.Semantic proximity Read ↗

Molecular targets in acute myelogenous leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.